$CORT news
The latest CORT stock news: headlines, filings, AI summaries and sentiment for $CORT, updated around the clock.
- Corcept Therapeutics Reports Q3 2026 Revenue Growth Driven by Lifyorli and Endocrinology Sales
- Corcept Therapeutics Reaffirms 2026 Revenue Guidance Amid Relacorilant FDA Decision Anticipation
- CORCEPT THERAPEUTICS INC - 10-Q Filing
- CORCEPT THERAPEUTICS INC - 8-K Filing
- CORCEPT THERAPEUTICS INC - 8-K Filing
- Bloom Energy, Illumina, Everpure Added to S&P Indices in September Rebalance
- Corcept Therapeutics Reports Strong Q2 Earnings Driven by LIFYORLI Launch
- CORCEPT THERAPEUTICS INC - 10-Q Filing
- CORCEPT THERAPEUTICS INC - 8-K Filing
- Corcept's CFO Sells Shares via Pre-Set Plan Amid Stock Volatility
- Corcept Director Sells Shares Amid Stock Recovery
- Corcept Insider Sells Shares Following FDA Approval and $1.05 Billion Outlook
- Corcept Insider Sells Shares Following FDA Approval and $1.05 Billion Outlook
- Crinetics Pharmaceuticals Shares Surge Over 99% on $10 Billion Acquisition Deal with Vertex
- Alger Russell Innovation Index Updates for Q2 2026
- CORCEPT THERAPEUTICS INC - 8-K Filing
- Corcept Therapeutics (CORT) Reports Q2 2025 Earnings Results
- Corcept Therapeutics (CORT) Reports Q1 2025 Earnings Results
- Corcept Therapeutics (CORT) Reports Q4 2025 Earnings with Revenue Growth and Guidance Update
- Corcept (CORT) Reports Q1 2026 Earnings with Revenue Growth and Guidance Increase
- Corcept Therapeutics (CORT) Upgraded Following FDA Approval of Lifyorli for Ovarian Cancer